Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

BACKGROUND: Intravenous immunoglobulin (IVIG) has been used as an immunomodulatory therapy to counteract severe systemic inflammation in coronavirus disease 2019 (COVID-19). But its use in COVID-19 related acute respiratory distress syndrome (ARDS) is not well established. METHODS: We conducted a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Husain S., Elshafei, Moustafa S., Saad, Mohamed O., Mitwally, Hassan A., Al Wraidat, Mohammad, Aroos, Asra, Shaikh, Nissar, Ananthegowda, Dore C., Abdelaty, Mohamed A., George, Saibu, Nashwan, Abdulqadir J., Mohamed, Ahmed S., Khatib, Mohamad Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572690/
https://www.ncbi.nlm.nih.gov/pubmed/34743710
http://dx.doi.org/10.1186/s12890-021-01717-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572690/
https://www.ncbi.nlm.nih.gov/pubmed/34743710
http://dx.doi.org/10.1186/s12890-021-01717-x

Ejemplares similares